127 related articles for article (PubMed ID: 33259119)
1. An Economical High-Throughput "FP-Tag" Assay for Screening Glycosyltransferase Inhibitors*.
Yin X; Li J; Chen S; Wu Y; She Z; Liu L; Wang Y; Gao Z
Chembiochem; 2021 Apr; 22(8):1391-1395. PubMed ID: 33259119
[TBL] [Abstract][Full Text] [Related]
2. Versatile O-GlcNAc transferase assay for high-throughput identification of enzyme variants, substrates, and inhibitors.
Kim EJ; Abramowitz LK; Bond MR; Love DC; Kang DW; Leucke HF; Kang DW; Ahn JS; Hanover JA
Bioconjug Chem; 2014 Jun; 25(6):1025-30. PubMed ID: 24866374
[TBL] [Abstract][Full Text] [Related]
3. A small molecule that inhibits OGT activity in cells.
Ortiz-Meoz RF; Jiang J; Lazarus MB; Orman M; Janetzko J; Fan C; Duveau DY; Tan ZW; Thomas CJ; Walker S
ACS Chem Biol; 2015 Jun; 10(6):1392-7. PubMed ID: 25751766
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAc transferase inhibitors: current tools and future challenges.
Trapannone R; Rafie K; van Aalten DM
Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193
[TBL] [Abstract][Full Text] [Related]
5. Discovery of O-GlcNAc transferase inhibitors.
Gross BJ; Kraybill BC; Walker S
J Am Chem Soc; 2005 Oct; 127(42):14588-9. PubMed ID: 16231908
[TBL] [Abstract][Full Text] [Related]
6. Bisubstrate Ether-Linked Uridine-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.
Makwana V; Ryan P; Malde AK; Anoopkumar-Dukie S; Rudrawar S
ChemMedChem; 2021 Feb; 16(3):477-483. PubMed ID: 32991074
[TBL] [Abstract][Full Text] [Related]
7. O-GlcNAc Transferase: Structural Characteristics, Catalytic Mechanism and Small-Molecule Inhibitors.
Ju Kim E
Chembiochem; 2020 Nov; 21(21):3026-3035. PubMed ID: 32406185
[TBL] [Abstract][Full Text] [Related]
8. Targeted covalent inhibition of O-GlcNAc transferase in cells.
Worth M; Hu CW; Li H; Fan D; Estevez A; Zhu D; Wang A; Jiang J
Chem Commun (Camb); 2019 Oct; 55(88):13291-13294. PubMed ID: 31626249
[TBL] [Abstract][Full Text] [Related]
9. Thio-Linked UDP-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.
Rafie K; Gorelik A; Trapannone R; Borodkin VS; van Aalten DMF
Bioconjug Chem; 2018 Jun; 29(6):1834-1840. PubMed ID: 29723473
[TBL] [Abstract][Full Text] [Related]
10. Identification of selective inhibitors for the glycosyltransferase MurG via high-throughput screening.
Hu Y; Helm JS; Chen L; Ginsberg C; Gross B; Kraybill B; Tiyanont K; Fang X; Wu T; Walker S
Chem Biol; 2004 May; 11(5):703-11. PubMed ID: 15157881
[TBL] [Abstract][Full Text] [Related]
11. High-Throughput "FP-Tag" Assay for the Identification of Glycosyltransferase Inhibitors.
Gao Z; Ovchinnikova OG; Huang BS; Liu F; Williams DE; Andersen RJ; Lowary TL; Whitfield C; Withers SG
J Am Chem Soc; 2019 Feb; 141(6):2201-2204. PubMed ID: 30698425
[TBL] [Abstract][Full Text] [Related]
12. Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors.
Martin SES; Tan ZW; Itkonen HM; Duveau DY; Paulo JA; Janetzko J; Boutz PL; Törk L; Moss FA; Thomas CJ; Gygi SP; Lazarus MB; Walker S
J Am Chem Soc; 2018 Oct; 140(42):13542-13545. PubMed ID: 30285435
[TBL] [Abstract][Full Text] [Related]
13. A Direct Fluorescent Activity Assay for Glycosyltransferases Enables Convenient High-Throughput Screening: Application to O-GlcNAc Transferase.
Alteen MG; Gros C; Meek RW; Cardoso DA; Busmann JA; Sangouard G; Deen MC; Tan HY; Shen DL; Russell CC; Davies GJ; Robinson PJ; McCluskey A; Vocadlo DJ
Angew Chem Int Ed Engl; 2020 Jun; 59(24):9601-9609. PubMed ID: 32092778
[TBL] [Abstract][Full Text] [Related]
14. Bisubstrate UDP-peptide conjugates as human O-GlcNAc transferase inhibitors.
Borodkin VS; Schimpl M; Gundogdu M; Rafie K; Dorfmueller HC; Robinson DA; van Aalten DM
Biochem J; 2014 Feb; 457(3):497-502. PubMed ID: 24256146
[TBL] [Abstract][Full Text] [Related]
15. Identification of active-site inhibitors of MurG using a generalizable, high-throughput glycosyltransferase screen.
Helm JS; Hu Y; Chen L; Gross B; Walker S
J Am Chem Soc; 2003 Sep; 125(37):11168-9. PubMed ID: 16220917
[TBL] [Abstract][Full Text] [Related]
16. Label-free electrochemical biosensing of small-molecule inhibition on O-GlcNAc glycosylation.
Yang Y; Gu Y; Wan B; Ren X; Guo LH
Biosens Bioelectron; 2017 Sep; 95():94-99. PubMed ID: 28427012
[TBL] [Abstract][Full Text] [Related]
17. Novel bisubstrate uridine-peptide analogues bearing a pyrophosphate bioisostere as inhibitors of human O-GlcNAc transferase.
Ryan P; Shi Y; von Itzstein M; Rudrawar S
Bioorg Chem; 2021 May; 110():104738. PubMed ID: 33667901
[TBL] [Abstract][Full Text] [Related]
18. OGT: a short overview of an enzyme standing out from usual glycosyltransferases.
Aquino-Gil M; Pierce A; Perez-Cervera Y; Zenteno E; Lefebvre T
Biochem Soc Trans; 2017 Apr; 45(2):365-370. PubMed ID: 28408476
[No Abstract] [Full Text] [Related]
19. Discovery of a Low Toxicity O-GlcNAc Transferase (OGT) Inhibitor by Structure-based Virtual Screening of Natural Products.
Liu Y; Ren Y; Cao Y; Huang H; Wu Q; Li W; Wu S; Zhang J
Sci Rep; 2017 Sep; 7(1):12334. PubMed ID: 28951553
[TBL] [Abstract][Full Text] [Related]
20. Discovery of two non-UDP-mimic inhibitors of O-GlcNAc transferase by screening a DNA-encoded library.
Balsollier C; Bijkerk S; de Smit A; van Eekelen K; Bozovičar K; Husstege D; Tomašič T; Anderluh M; Pieters RJ
Bioorg Chem; 2024 Jun; 147():107321. PubMed ID: 38604018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
